Clinical Trial Update: Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology

View source ↗

Summary

A completed clinical trial evaluating nanoparticles in the lung and bronchi across interstitial lung diseases and examining their relationship to disease etiolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Interstitial Lung Diseases | Status: COMPLETED